Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-66.56%Free Cash Flow Margin
VS
Market
Sector
Industry
History
$ 2.21Close
$ 0.56 - $ 3.04 52-Week Range
Ticker Information
Ticker
SPROCompany Name
SPERO THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSPERO THERAPEUTICS INC - Free Cash Flow Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SPRO - FCF % Historical data
| Date | Free Cash Flow | Free Cash Flow Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -32.33M | -66.56% | $ 48.58M |
| 3/31/2025 | $ -33.38M | -74.88% | $ 44.58M |
| 12/31/2024 | $ -23.44M | -48.87% | $ 47.98M |
| 9/30/2024 | $ -17.54M | -16.47% | $ 106.45M |
| 6/30/2024 | $ -14.38M | -12.14% | $ 118.46M |
| 3/31/2024 | $ -14.2M | -12.8% | $ 110.98M |
| 12/31/2023 | $ -32.99M | -31.79% | $ 103.78M |
| 9/30/2023 | $ 28.98M | 37.3% | $ 77.7M |
| 6/30/2023 | $ 12.11M | 22.33% | $ 54.23M |
| 3/31/2023 | $ 7.64M | 14.28% | $ 53.51M |
Key Performance Insights, Last 5 Years
- SPERO THERAPEUTICS INC's latest trailing twelve months (TTM) FCF % stands at -788.29%.
- Over the past 5 years, SPERO THERAPEUTICS INC's average FCF % has been -290.9%.
- The median FCF % for SPERO THERAPEUTICS INC during this period was -70.72%
- SPERO THERAPEUTICS INC reached its highest FCF % over the past 5 years at 37.3%.
- The lowest FCF % recorded by SPERO THERAPEUTICS INC in the same timeframe -922.07%
SPERO THERAPEUTICS INC's FCF % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF % Benchmarks
Similar metrics to Revenues:
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
Definition of Free Cash Flow Margin
[Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.FCF / Revenues
(=) FCF % FCF % for SPERO THERAPEUTICS INC is calculated as follows: FCF [ $ -87.13M ] / Revenues [ $ 11.05M ]
(=) FCF % [ -788.29% ] SPRO - Free Cash Flow Margin, Last 5 years
-922.07%
Minimum
Dec 31, 2020
37.3%
Maximum
Sep 30, 2023
-290.9%
Average
-70.72%
Median
FCF % Benchmark AnalysisMarket
The chart above depicts the distribution of FCF % for companies in the Total Stock Market. The average FCF % of the companies is 7.85% with a standard deviation of 19.48%.
The following table provides additional summary stats:
FCF % in the Market:
| filtered constituents | 3.18K |
|---|---|
| min | -58.23% |
| max | 68.19% |
| average | 7.85% |
| median | 7.37% |
| std | 19.48% |